| karyotyping | ovulation stimulation | No of blastocyst/ eggs | Euploid embryos | Embryo transfer | Prenatal diagnosis |
---|---|---|---|---|---|---|
Case 1 | 46, XX, der(6)(6qter → 6q23.3::6p12 → 6q11::11p11.2 → 11pter, der(11)(6pter → 6p12::6q23.3 → 6q11::11p11.2 → 11qter) | GnRH antagonist | 6/24 | 3 | yes | CMA (-) monochorionic twins, healthy |
Case 2 | 46,XX,t(12;22;15)(p10;p10;q10) | GnRH antagonist | 9/36 | 4 | yes | CMA (-) singleton, healthy |
Case 3 | 45, XX, der(13;14)(q10;q10)t(13;18)(q13;q22) | GnRH antagonist | 3/4 | 0 | N/A | / |
Case 4 | 45, XX, der(13;14) (q10;q10);t(5;16)(q24;p13.1) | GnRH antagonist | 2/10 | 1 | yes | CMA (-); 46, X?,t(15;16)(q24;p13.1)mat, singleton, healthy |
Case 5 | 46, XX, inv(2) (p12p22)t(15;22)(q15;q11.2) | GnRH antagonist | 3/9 | 2 | yes | CMA (-) singleton, healthy |
Case 6 | 46,XX,t(1;6)(p31.1;q16.1);inv(6)(p21.3q16.1) | GnRH antagonist | 4/9 | 1 | yes | / |
long agonist | 7/15 | 4 | yes | CMA (-) singleton, healthy | ||
Case 7 | 46,XY, inv(5)(q11.2q22)t(5;8)(q22;q11.2) | GnRH antagonist | 5/15 | 3 | yes | CMA + karyotyping (-) singleton, healthy |